SOLIAN
As listed in the register: SOLIAN 200 mg/4 ml, solution injectable
200 mg · solution injectable
- Prescription only
- Active substance
- Amisulpride
- Made by
- SANOFI WINTHROP INDUSTRIE
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Barhemsys). It describes the substance, not this exact product.
Amisulpride is a selective dopamine-2 (D 2 ) and dopamine-3 (D 3 ) receptor antagonist.
D 2 receptors are located in the chemoreceptor trigger zone (CTZ) and respond to the dopamine released from the nerve endings.
In vitro amisulpride is not metabolized by major cytochrome P450 enzymes.
After intravenous administration of amisulpride, 74% and 23% of the administered dose was recovered in urine and feces, respectively. 58% and 20% of the dose was excreted as unchanged amisulpride in urine and feces, respectively.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-06-17
Safety of the active substance
From the US prescribing label for the same active substance (Barhemsys). It describes the substance, not this exact product.
- BARHEMSYS is contraindicated in patients with known hypersensitivity to amisulpride [see Adverse Reactions (6.2) ].
- Known hypersensitivity to amisulpride.
Most common adverse reactions (≥ 2%) are: Prevention of PONV: increased blood prolactin concentrations, chills, hypokalemia, procedural hypotension, and abdominal distension.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | SANOFI WINTHROP INDUSTRIE |
|---|---|
| Active substance | Amisulpride |
| Strength | 200 mg |
| Form | solution injectable |
| Route | intramusculaire |
| Dispensing (as stated by the register) | liste I |
| Marketed | No — authorised but not currently marketed, according to the register |
| Authorisation procedure | Procédure nationale |
| Name in the register | SOLIAN 200 mg/4 ml, solution injectable |
| Packs | 6 ampoule(s) en verre de 4 ml |
| CIS | 63697872 |
| CIP13 | 3400933220815 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
5 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.